Back to medications
Medication monograph
abacavir
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)Antiretroviral AgentsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase InhibitorNucleoside and Nucleotide Reverse Transcriptase InhibitorsHIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Clinical reference
Product monograph
ABACAVIR- abacavir sulfate solution
ABACAVIR tablet, film coated
Brands & formulations
Family members
Pricing
Price information
Epzicom
ViiV Healthcare · 600 mg/300 mg
: $: $: $
Abacavir/Lamivudine
Generic · 600 mg/300 mg
30: $714.2760: $1257.1390: $1785.7
Kivexa Tablet
ViiV Healthcare · 600 mg/300 mg
30: $1318.5660: $2575.790: $3854.27
Abacavir/Lamivudine Tablet
Generic · 600 mg/300 mg
30: $714.2760: $1257.1390: $1785.7
Triumeq Tablet
ViiV Healthcare · 600 mg/50 mg/300 mg
30: $2288.56
Trizivir
GSK · 300 mg/150 mg/300 mg
60: $1645.7
Abacavir
Generic · 300 mg
60: $594.27120: $1167.13180: $1739.99
Classification
- Chemical class
- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Clinical class
- Antiretroviral Agents
- Banks class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
- AHFS family
- HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors